newsfilter
← Latest News
ACCESS Newswire·

Xenetic Biosciences, Inc. Announces Abstract Acceptance for Presentation at the 2026 ASCO Annual Meeting

FRAMINGHAM, MA / ACCESS Newswire / April 22, 2026 / Xenetic Biosciences, Inc. , a biopharmaceutical company focused on advancing innovative immuno-oncology technologies